- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Athira Pharma (NASDAQ:ATHA), Quotes and News Summary
Athira Pharma (NASDAQ: ATHA)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-15 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.550 | -0.560 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Athira Pharma Questions & Answers
You can purchase shares of Athira Pharma (NASDAQ: ATHA) through any online brokerage.
There are no as such competitors for Athira Pharma.
The latest price target for Athira Pharma (NASDAQ: ATHA) was reported by Stifel on Thursday, June 23, 2022. The analyst firm set a price target for 5.00 expecting ATHA to rise to within 12 months (a possible 47.49% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Athira Pharma (NASDAQ: ATHA) is $3.39 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for Athira Pharma.
Athira Pharma’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Athira Pharma.
Athira Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.